Key points are not available for this paper at this time.
Procaine amide, a new synthetic analogue of procaine, has marked antiarrythmic activity and is relatively stable in the body. It is effective when administered orally or intravenously, and has few toxic effects in therapeutic doses. The drug has been used successfully in the suppression of ventricular premature contractions and in the interruption of ventricular tachycardia. Some patients treated successfully with procaine amide had been given quinidine to the point of toxicity without affecting the aberrant rhythm. Procaine amide appears to be less effective in interrupting auricular than ventricular arrhythmias.
Building similarity graph...
Analyzing shared references across papers
Loading...
Herbert J. Kayden
Université Libre de Bruxelles
J. Murray Steele
Queen's University
Lester C. Mark
Hospital for Special Surgery
Circulation
Memorial Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Kayden et al. (Sun,) studied this question.
synapsesocial.com/papers/6a22b1fb29c8bdba62cd5c16 — DOI: https://doi.org/10.1161/01.cir.4.1.13
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: